NCT05445284View on ClinicalTrials.gov

Group Education Trial to Improve Transition for Parents of Adolescents With T1D

NAActive, not recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 10, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

March 31, 2026

Conditions
Diabetes MellitusDiabetes Mellitus, Type 1Glucose Metabolism DisordersMetabolic DiseaseEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases
Interventions
BEHAVIORAL

Group education sessions for parents plus usual diabetes care

≥3 in person/virtual group education sessions for parents in addition to usual diabetes care, every 3 months for 12 months

OTHER

Usual diabetes care

Usual diabetes care, every 3-month for 12 months

Trial Locations (1)

H4A 3J1

Montreal Children's Hospital - McGill University Health Centre (MUHC), Montreal

All Listed Sponsors
collaborator

Diabetes Canada

OTHER

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT05445284 - Group Education Trial to Improve Transition for Parents of Adolescents With T1D | Biotech Hunter | Biotech Hunter